Abalos Therapeutics GmbH
- Biotech or pharma, therapeutic R&D
At Abalos, we develop a highly differentiated immuno-therapy approach for cancers that are currently hard to treat. Our first-in-class products make tumours immuno-visible and activate all key components of the immune system in a concerted, body-wide attack against cancer. We are on track to start clinical trials with our lead product in the next few months. I am looking forward to attend BIO and meet investors and partners that want to learn more about our unique efforts to treat more cancer patients, better.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}